Targeting topoisomerase I cleavage to specific sequences of DNA by triple helix-forming oligonucleotide conjugates. A comparison between a rebeccamycin derivative and camptothecin-Reference-Cited by-同舟云学术

Targeting topoisomerase I cleavage to specific sequences of DNA by triple helix-forming oligonucleotide conjugates. A comparison between a rebeccamycin derivative and camptothecin

Published:1999-09 Issue:9 Volume:322 Page:785-790
ISSN:0764-4469
Container-title:Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie
language:en
Short-container-title:Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie

Author:

Arimondo Paola B,Bailly Christian,Boutorine Alexandre,Sun Jian-Sheng,Garestier Thérèse,Hélène Claude

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,Ecology

Reference18 articles.

1. Prospects for the therapeutic use of antigene oligonucleotides;Maher;Cancer Invest.,1996

2. Progress in developments of triplex-based strategies;Giovannangeli;Antisense Nucleic Acid Drug Dev.,1997

3. Triplex-directed modification of genes and gene activity;Vasquez;Trends Biochem. Sci.,1998

4. Contrôle sélectif de l'expression des gènes par des oligonucléotides. Stratégies antisens et triple-hélice;Guieysse-Peugeot;Hématologie,1997

5. DNA topoisomerases;Wang;Annu. Rev. Biochem.,1996

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oligonucleotide-Recognizing Topoisomerase Inhibitors (OTIs): Precision Gene Editors for Neurodegenerative Diseases?;International Journal of Molecular Sciences;2022-09-29

2. Sequence-Specific Base Pair Mimics Are Efficient Topoisomerase IB Inhibitors;Biochemistry;2011-12-23

3. Replication-Fork Stalling and Processing at a Single Psoralen Interstrand Crosslink in Xenopus Egg Extracts;PLoS ONE;2011-04-15

4. Optimized Synthesis and Enhanced Efficacy of Novel Triplex-Forming Camptothecin Derivatives Based on Gimatecan;Bioconjugate Chemistry;2009-03-23

5. Camptothecins for drug design, cancer cell death and gene targeting;Cancer Drug Design and Discovery;2008